NCT05578404View on ClinicalTrials.gov

High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DRUG

Cholecalciferol

Vit D is a fat-soluble vitamin, provided by sunlight and activated by kidneys and liver.

DRUG

Placebo

matching placebo to Vit D

Trial Locations (1)

31527

Tanta Unuversity, Tanta

All Listed Sponsors
lead

Tanta University

OTHER